vs

Side-by-side financial comparison of Metalpha Technology Holding Ltd (MATH) and Silence Therapeutics plc (SLN). Click either name above to swap in a different company.

Silence Therapeutics plc is the larger business by last-quarter revenue ($15.7M vs $12.0M, roughly 1.3× Metalpha Technology Holding Ltd). Silence Therapeutics plc runs the higher net margin — -14.7% vs -24.0%, a 9.3% gap on every dollar of revenue.

Metalpha Technology Holding Ltd is a global fintech firm specializing in digital asset wealth management, institutional-grade crypto investment services, and Web3 ecosystem infrastructure support. It serves professional investors, financial institutions, and high-net-worth clients across Asia, North America and Europe, with core segments including structured digital asset products, risk management solutions and DeFi technology development.

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

MATH vs SLN — Head-to-Head

Bigger by revenue
SLN
SLN
1.3× larger
SLN
$15.7M
$12.0M
MATH
Higher net margin
SLN
SLN
9.3% more per $
SLN
-14.7%
-24.0%
MATH

Income Statement — Q3 FY2025 vs Q1 FY2024

Metric
MATH
MATH
SLN
SLN
Revenue
$12.0M
$15.7M
Net Profit
$-2.9M
$-2.3M
Gross Margin
28.3%
82.2%
Operating Margin
-24.2%
-35.6%
Net Margin
-24.0%
-14.7%
Revenue YoY
-39.0%
Net Profit YoY
-147.7%
EPS (diluted)
$-0.07
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MATH
MATH
SLN
SLN
Q3 25
$12.0M
Q1 25
$24.8M
Q3 24
$19.7M
Q1 24
$15.7M
Net Profit
MATH
MATH
SLN
SLN
Q3 25
$-2.9M
Q1 25
$9.8M
Q3 24
$6.0M
Q1 24
$-2.3M
Gross Margin
MATH
MATH
SLN
SLN
Q3 25
28.3%
Q1 25
85.7%
Q3 24
49.5%
Q1 24
82.2%
Operating Margin
MATH
MATH
SLN
SLN
Q3 25
-24.2%
Q1 25
39.3%
Q3 24
38.9%
Q1 24
-35.6%
Net Margin
MATH
MATH
SLN
SLN
Q3 25
-24.0%
Q1 25
39.6%
Q3 24
30.7%
Q1 24
-14.7%
EPS (diluted)
MATH
MATH
SLN
SLN
Q3 25
$-0.07
Q1 25
$0.25
Q3 24
$0.16
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MATH
MATH
SLN
SLN
Cash + ST InvestmentsLiquidity on hand
$10.1M
Total DebtLower is stronger
$101.2K
Stockholders' EquityBook value
$35.1M
$156.8M
Total Assets
$413.8M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MATH
MATH
SLN
SLN
Q3 25
$10.1M
Q1 25
$6.9M
Q3 24
$3.8M
Q1 24
Total Debt
MATH
MATH
SLN
SLN
Q3 25
$101.2K
Q1 25
$188.0K
Q3 24
$275.1K
Q1 24
Stockholders' Equity
MATH
MATH
SLN
SLN
Q3 25
$35.1M
Q1 25
$36.6M
Q3 24
$25.3M
Q1 24
$156.8M
Total Assets
MATH
MATH
SLN
SLN
Q3 25
$413.8M
Q1 25
$246.8M
Q3 24
$237.2M
Q1 24
Debt / Equity
MATH
MATH
SLN
SLN
Q3 25
0.00×
Q1 25
0.01×
Q3 24
0.01×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MATH
MATH
SLN
SLN
Operating Cash FlowLast quarter
$3.3M
$-9.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MATH
MATH
SLN
SLN
Q3 25
$3.3M
Q1 25
$16.2M
Q3 24
$-16.1M
Q1 24
$-9.1M
Capex Intensity
MATH
MATH
SLN
SLN
Q3 25
Q1 25
Q3 24
Q1 24
0.0%
Cash Conversion
MATH
MATH
SLN
SLN
Q3 25
Q1 25
1.64×
Q3 24
-2.66×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons